Anca Ligia Grosu MD, Moderator: Nothing to Disclose

1) To understand challenges of morphological radiological investigations for the detection and characterization of tumor biology and the timely assessment of tumor response in clinical cancer therapy and in clinical trials testing new therapy regimens. 2) To understand the role and the potential of functional and molecular imaging modalities and techniques used (a) prior to therapy for tumor delineation and targeting, (b) during cytotoxic therapy, such as radiation and chemotherapy for intra-treatment tumor response monitoring, and (c) after cytotoxic therapy for response assessment. 3) To apply and integrate imaging modalities into the therapeutic management of cancer. 4) To review the role of imaging as predictors of tumor control and survival and their emerging role as short-term surrogate markers for long-term therapeutic outcome of cancer treatment regimens and its potential for adaptive therapy.

Grosu, A, Molecular and Functional Imaging/Surrogate Markers in Radiation Oncology.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14002107.html